Security key
00461U105
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)
CUSIP: 00461U105
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Stock, $0.00001 par value
- Total 13F shares
- 23,711,078
- Total 13F value
- $707,195,746
- Share change
- +2,390,546
- SEC-reported price per share
- $29.82
- Number of holders
- 111
- Value change
- +$74,703,828
- Number of buys
- 70
- Number of sells
- 48
- Shares outstanding
- 138,752,791
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
111
Top holders
10
ACRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Aclaris Therapeutics, Inc. SEC filings
Aclaris Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00461U105
Recent filing periods:
Ownership snapshot
Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital, LLC
Disclosed value leader
Vivo Capital, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 2.4%
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital, LLC leads the comparable SEC ownership view at 2.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital, LLC
2.4%
Sofinnova Management VIII, L.L.C.
1.7%
FRANKLIN RESOURCES INC
1.1%
PERCEPTIVE ADVISORS LLC
0.91%
Rock Springs Capital Management LP
0.79%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
Company
|
2.4%
|
$89,116,000
3,283,569 shares
|
— | 31 Dec 2016 |
| Sofinnova Management VIII, L.L.C. |
13F
Company
|
1.7%
|
$62,136,000
2,289,480 shares
|
— | 31 Dec 2016 |
| FRANKLIN RESOURCES INC |
13F
Company
|
1.1%
|
$41,457,000
1,527,549 shares
|
— | 31 Dec 2016 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
0.91%
|
$34,219,000
1,260,847 shares
|
— | 31 Dec 2016 |
| Rock Springs Capital Management LP |
13F
Company
|
0.79%
|
$29,854,000
1,100,000 shares
|
— | 31 Dec 2016 |
| Cormorant Asset Management, LP |
13F
Company
|
0.7%
|
$26,496,000
976,286 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
111
Shares
23,711,078
Rows available
111
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
100
Q1 2017 holders
111
Holder diff
11
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend